Treat 2019 novel coronavirus (COVID-19) with IL-6 inhibitor: Are we already that far?
{{output}}
The world is in the midst of the coronavirus disease 2019 (COVID-19) pandemic. Interleukin 6 (IL-6) inhibitor (tocilizumab) had been suggested for the treatment of acute respiratory distress syndrome (ARDS) patients based on the concept of "cytokine storm" in ... ...
